Longs Drug to give shareholders closer look at CVS deal

SAN FRANCISCO (MarketWatch) - Longs Drug Stores Corp. has agreed to hand over more information to pension funds suing the drug-store chain over its proposed $2.9 billion sale to CVS Caremark Corp., a lawyer involved in the case said Tuesday. 2 months ago